FDA template copy here: https://www.fda.gov/media/140615/download
Criteria within the template outlines that, "This template is intended for testing with respiratory specimens or saliva; if you are considering non-respiratory specimens (e.g., blood, stool, etc.), please contact FDA at CDRH-EUA-Templates ([email protected]) to discuss your validation strategy".
So this template announcement is not for Access Bio (Atomo) kit since its a blood based test. However, no doubt Access Bio would be pursuing emergency FDA approval for its kit as advised by John Kelly in the partnership announcement + IRD Investor presentation yesterday.
Broker Target Price of $0.65, page-5
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AT1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
-0.001(5.00%) |
Mkt cap ! $12.14M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.1¢ | 1.9¢ | $3.016K | 150.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 628443 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 291292 | 2 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| AT1 (ASX) Chart |